Shuttle Pharmaceuticals Statistics Share Statistics Shuttle Pharmaceuticals has 1.07M
shares outstanding. The number of shares has increased by 0.47%
in one year.
Shares Outstanding 1.07M Shares Change (YoY) 0.47% Shares Change (QoQ) 0.47% Owned by Institutions (%) 0.52% Shares Floating 933.53K Failed to Deliver (FTD) Shares 4,386 FTD / Avg. Volume 2.64%
Short Selling Information The latest short interest is 40.69K, so 8.82% of the outstanding
shares have been sold short.
Short Interest 40.69K Short % of Shares Out 8.82% Short % of Float 9.38% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.02 and the forward
PE ratio is null.
Shuttle Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.02 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.31 P/FCF Ratio -30.27 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Shuttle Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.44,
with a Debt / Equity ratio of 0.
Current Ratio 1.44 Quick Ratio 1.44 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF -0.16 Interest Coverage -5658.3
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.02B Employee Count 9 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -94.22% in the
last 52 weeks. The beta is 0.42, so Shuttle Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.42 52-Week Price Change -94.22% 50-Day Moving Average 3.97 200-Day Moving Average 13.58 Relative Strength Index (RSI) 39.44 Average Volume (20 Days) 165,839
Income Statement
Revenue n/a Gross Profit n/a Operating Income -7.7B Net Income -9.14B EBITDA -7.7B EBIT -9.15B Earnings Per Share (EPS) -885.73
Full Income Statement Balance Sheet The company has 1.92M in cash and 1.17M in
debt, giving a net cash position of 746.67K.
Cash & Cash Equivalents 1.92M Total Debt 1.17M Net Cash 746.67K Retained Earnings -34.58B Total Assets 5.31M Working Capital 3.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.33M
and capital expenditures 0, giving a free cash flow of -7.33M.
Operating Cash Flow -7.33M Capital Expenditures n/a Free Cash Flow -7.33M FCF Per Share -0.71
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SHPH does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SHPH.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 16, 2025. It was a
backward
split with a ratio of 1:25.
Last Split Date Jun 16, 2025 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -14.02 Piotroski F-Score 3
